Table 1. The status of current malaria pre-erythrocytic stage vaccine candidates (adapted from the World Health Organization tables of malaria vaccine projects globally—’Rainbow Tables’) 172 .
Whole Sporozoite | |||||||
PfSPZ | NCT02215707 | Sanaria Inc | RAS | USA | I | 2014 | 51 |
PfSPZ | NCT02627456 | Sanaria Inc | RAS | Mali | II | 2016 | |
PfSPZ | NCT02613520 | Sanaria Inc | RAS | Tanzania | I | 2015 | 27,173 |
PfRAS | NCT01994525 | USAMRDC | RAS | USA | I | 2013 | |
PfSPZ-CVac | NCT02115516 | Sanaria Inc | CPS (SPZ-CQ) | Germany | I | 2014 | 54 |
PfGAP3KO | NCT03168854 | NIAID | GAP | USA | I | 2017 | |
PfSPZ | NCT02663700 | NIAID | RAS | Burkina Faso, USA | I | 2016 | |
PfSPZ-CVac | NCT02773979 | NIAID | CPS (SPZ-CQ) | USA | I | 2016 | |
Sub-unit | |||||||
RTS,S/AS01E | NCT02374450 | GSK | CSP | Kenya, Burkina Faso, Ghana | IV | 2015 | 174 |
RTS,S/AS01 fractional dose | NCT01857869 | GSK | CSP | Kenya, Gambia, Burkina Faso | II | 2013 | 61 |
R21/AS01B | NCT02600975 | University of Oxford | CSP | United Kingdom | I | 2015 | |
R21/Matrix – M1 | NCT02925403 | University of Oxford | CSP | Burkina Faso | I | 2016 | |
R21/ME-TRAP | NCT02905019 | University of Oxford | CSP/TRAP | United Kingdom | II | 2016 | 175 |
CS-Vac | NCT01450280 | University of Oxford | CSP | Ireland | I | 2011 | 65 |
PfCelTOS FMP012/AS01B | NCT02174978 | USAMRMC | CelTOS | USA | I | 2014 | |
ChAd63/MVA ME-TRAP | NCT01635647 | University of Oxford | ME-TRAP | Burkina Faso, Kenya, Gambia | II | 2012 | 72-74 |
ChAd63/MVA ME-TRAP + Matrix M™ | NCT01663512 | University of Oxford | ME-TRAP | United Kingdom | I | 2012 | 176 |
Note: RAS denotes radiation-attenuated sporozoites.
Abbreviations: Adjuv, adjuvant; CelTOS, cell-traversal protein for ookinetes and sporozoites; ChAd, chimpanzee adenovirus; CPS, chemoprophylaxis following sporozoite infection; CQ, chloroquine; CSP, circumsporozoite protein; GAP, genetically attenuated parasites; GSK, GlaxoSmithKline; KO, knockout; MVA, modified vaccinia Ankara; NIAID, National Institute of Allergy and Infectious Diseases; Pf, Plasmodium falciparum; SPZ, sporozoites; TRAP, thrombospondin-related anonymous protein; USAMRDC, United States Army Medical Research and Development Command.